Currently, KRAS mutations are hot-spot driver mutations and the most frequent KRAS mutant is KRAS G12D that is expressed in ∼45% of pancreatic adenocarcinomas (Bryant et al., 2014) and ∼13% of colorectal cancers (Vaughn et al., 2011). The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.